Natural Killer Cells: Development, Maturation, and Clinical Utilization
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express polymorphic clonotypic receptors and utilize inhibitory receptors (killer immunoglobulin-like recept...
Main Authors: | Alex M. Abel, Chao Yang, Monica S. Thakar, Subramaniam Malarkannan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01869/full |
Similar Items
-
Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
by: Monica S. Thakar, et al.
Published: (2020-01-01) -
Transcriptional Regulation of NK Cell Development by mTOR Complexes
by: Chao Yang, et al.
Published: (2020-11-01) -
The Fyn-ADAP axis: Cytotoxicity versus Cytokine Production in Killer Cells
by: Subramaniam eMalarkannan
Published: (2015-09-01) -
IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
by: Alex M. Abel, et al.
Published: (2018-05-01) -
Transcriptional Regulation of Natural Killer Cell Development and Functions
by: Dandan Wang, et al.
Published: (2020-06-01)